Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Coverage Under HSAs, FSAs Advanced By “Tax Parity” Coalition

This article was originally published in The Tan Sheet

Executive Summary

A group of dietary supplement marketers and trade associations has joined forces to promote dietary supplement coverage by tax-free health savings accounts and flexible spending accounts

You may also be interested in...



Capitol Hill In Brief

Harkin on NIH funding: Sen. Tom Harkin, D-Iowa, said at a March 19 appropriations subcommittee hearing he and ranking minority member Arlen Specter, R-Pa., will not allow proposed cuts in NIH funding. President Bush's proposed fiscal 2008 budget would cut NIH spending by $328 mil., but Harkin said the actual reduction will be about $529 mil. because NIH has to "pick up the entire tab for the global AIDS fund rather than sharing it with the State Department." Specter said with a federal budget of $2.9 tril., an allocation of less than $30 bil. to NIH is "scandalous." NIH Director Elias A. Zerhouni, M.D. said the cut would force the institute to reduce its number of clinical trials because they are "extremely expensive." Harkin said the subcommittee will hear from the directors of all NIH centers and institutes later this spring...

Capitol Hill In Brief

Harkin on NIH funding: Sen. Tom Harkin, D-Iowa, said at a March 19 appropriations subcommittee hearing he and ranking minority member Arlen Specter, R-Pa., will not allow proposed cuts in NIH funding. President Bush's proposed fiscal 2008 budget would cut NIH spending by $328 mil., but Harkin said the actual reduction will be about $529 mil. because NIH has to "pick up the entire tab for the global AIDS fund rather than sharing it with the State Department." Specter said with a federal budget of $2.9 tril., an allocation of less than $30 bil. to NIH is "scandalous." NIH Director Elias A. Zerhouni, M.D. said the cut would force the institute to reduce its number of clinical trials because they are "extremely expensive." Harkin said the subcommittee will hear from the directors of all NIH centers and institutes later this spring...

Capitol Hill In Brief

Harkin on NIH funding: Sen. Tom Harkin, D-Iowa, said at a March 19 appropriations subcommittee hearing he and ranking minority member Arlen Specter, R-Pa., will not allow proposed cuts in NIH funding. President Bush's proposed fiscal 2008 budget would cut NIH spending by $328 mil., but Harkin said the actual reduction will be about $529 mil. because NIH has to "pick up the entire tab for the global AIDS fund rather than sharing it with the State Department." Specter said with a federal budget of $2.9 tril., an allocation of less than $30 bil. to NIH is "scandalous." NIH Director Elias A. Zerhouni, M.D. said the cut would force the institute to reduce its number of clinical trials because they are "extremely expensive." Harkin said the subcommittee will hear from the directors of all NIH centers and institutes later this spring...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098439

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel